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Abstract
Objective
To describe antibiotic prescription rates for Australian Aboriginal children aged <2 years liv-
ing in three remote Northern Territory communities.
Design
A retrospective cohort study using electronic health records.
Setting
Three primary health care centres located in the Katherine East region.
Participants
Consent was obtained from 149 mothers to extract data from 196 child records. There were
124 children born between January 2010 and July 2014 who resided in one of the three cho-
sen communities and had electronic health records for their first two years of life.
Main outcome measures
Antibiotic prescription rates, factors associated with antibiotic prescription and factors asso-
ciated with appropriate antibiotic prescription.
Results
There were 5,675 Primary Health Care (PHC) encounters for 124 children (median 41, IQR
25.5, 64). Of the 5,675 PHC encounters, 1,542 (27%) recorded at least one infection (total
1,777) and 1,330 (23%) had at least one antibiotic prescription recorded (total 1,468).
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Children had a median five (IQR 2, 9) prescriptions in both their first and second year of life,
with a prescription rate of 5.99/person year (95% CI 5.35, 6.63). Acute otitis media was the
most common infection (683 records, 38%) and Amoxycillin was the most commonly pre-
scribed antibiotic (797 prescriptions, 54%). Of the 1,468 recorded prescriptions, 398 (27%)
had no infection recorded and 116 (8%) with an infection recorded were not aligned with
local treatment guidelines.
Conclusion
Prescription rates for Australian Aboriginal children in these communities are significantly
higher than that reported nationally for non-Aboriginal Australians. Prescriptions predomi-
nantly aligned with treatment guidelines in this setting where there is a high burden of infec-
tious disease.
Introduction
Antibiotics have saved millions of lives since modern refinements of ancient Chinese, Roman
and Greek preparations were undertaken in the early 1900s. [1] However, in this modern era
the overuse of antibiotics has resulted in the emergence of antimicrobial resistance (AMR) that
poses a significant threat to public health. [1, 2] By the year 2050, AMR is expected to directly
result in 10 million deaths per year. [3] Of particular concern is Australia’s antibiotic use,
which is ranked eighth for the highest use of antibiotics among the Organisation for Economic
Co-operation and Development (OECD) nations. [4] In response, the Australian government
introduced the First National Antimicrobial Resistance Strategy 2015–2019, with an aim to
combat the overuse of antibiotics and subsequent resistance. [5] As part of this strategy yearly
publications describing Antimicrobial Use and Resistance in Australia (AURA) have been pro-
duced. [2, 5]
In 2015, data from the Pharmaceutical Benefits Scheme (PBS) indicated 51% of Australian
children aged 0–4 years had been prescribed antibiotics. [2] However, this data does not cap-
ture remote primary health care (rPHC) services, who provide a significant proportion of pri-
mary health care (PHC) to Aboriginal people living in remote locations in Australia. In the
Northern Territory (NT), rPHC services are provided predominantly by Remote Area Nurses
(RANs) and Aboriginal Health Practitioners (AHPs), who conduct physical assessments and
supply and administer antibiotics in accordance with the Central Australian Remote Practi-
tioners Association Standard Treatment Manual (CARPA STM) [6]. Antibiotics are supplied
in bulk to the PHC services under the Remote Area Aboriginal Health Services program and
are thus not captured under the National PBS datasets. [7] The only record of who received
these antibiotics is held in the local PHC electronic health record.
Evidence suggests Australian Aboriginal children are prescribed antibiotics at a higher rate
than non-Aboriginal children of the same age. [8, 9] This is likely due to increased prevalence
of infectious diseases requiring antibiotics, a factor which is further heightened among Aborig-
inal children living remotely in the NT. [9, 10] PHC presentations for impetigo and otitis
media (OM) are frequent with 87% of children aged<24 months and 91% aged 6–30 months
attending a PHC service for which antibiotics were prescribed in 49% [11] and 48% [12] of
cases respectively. Furthermore, it has been suggested that increased sequalae risk may result
in a lowered prescribing threshold. [13] Despite the increased prevalence and risk from
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infections, it has been suggested that the appropriateness of antibiotic prescriptions is higher
in remote communities compared to urban areas. [9]
There is a significant dearth of data on prescription rates and prescription appropriateness
for antibiotic use in rPHC services. With AMR increasing, surveillance is needed in these com-
munities who, with an already high infection prevalence, are at particular risk. We report on
antibiotic prescriptions in the first two years of life for children born between 1 January 2010
and 31 July 2014 living in three remote NT Aboriginal communities.
Methods
Study design and setting
We conducted a retrospective cohort study to report on antibiotic prescriptions by remote
health practitioners for Aboriginal and/or Torres Strait Islander children born between 1 Janu-
ary 2010 and 31 July 2014 in three remote NT Aboriginal communities located in Katherine
East region, Australia. This study was embedded in a larger mixed-methods evaluation of
anaemia prevention and treatment that included infections and treatment for children up to
two years of age.
Katherine region is located in the tropical region of Australia (23.50 South) that has a wet
(October-March) and dry (April-September) season. Previous reports from tropical and sub-
tropical countries indicate significant differences in antibiotic prescriptions and infectious pre-
sentations by season. [14–16] All three communities are accessible by road in the dry season
but during the wet season two of the communities are often only accessible by air. [17] The
three community populations ranged from ~300–1000 [18] for which there were ~215 births
reported during the study period (personal communication from Data Custodian 2020).
Health care is provided by RANs, Midwives and AHPs who are based at the community rPHC
services and includes visiting Medical Officers and Allied Health Professionals.
Whilst acknowledging the diversity in Aboriginal and Torres Strait Islander peoples’ lan-
guages, culture and community populations, the provision and accessibility of PHC services
and the prevalence of infections are not dissimilar across the Top End of Australia. [19]
Participant recruitment and consent
From February to May 2016 locally trained Aboriginal Community Based Researchers went
house to house to discuss the research project with families who potentially had children born
between 1 January 2010 and 31 July 2014. Written informed consent was obtained from moth-
ers/caregivers who agreed to having the electronic health records of their child’s PHC presen-
tations in the first two years of life extracted for review. Participants were excluded if the child
was born outside the study period, or if no electronic health data was recorded during their
first two years of life.
Ethics approval was provided from the Human Research Ethics Committee (HREC) of the
Northern Territory Department of Health and Menzies School of Health Research HREC (Ref-
erence number 2015–2525).
Data extraction
From July to August 2016 an automated script was developed and modified by the local data
custodian to extract data from the electronic health record into comma-separated value (CSV)
files. Data variables used to merge the demographic CSV file with the reason for presentation
and medication CSV files included a unique person identifier (hospital record number–HRN)
and the date of the encounter. Other variables extracted included: Locality, Date of birth
PLOS ONE Antibiotic use for Australian Aboriginal children in three remote Northern Territory communities
PLOS ONE | https://doi.org/10.1371/journal.pone.0231798 April 17, 2020 3 / 15
(DOB), Birth weight, Gestation, Clinical items (i.e. observations general, immunisation,
review), Condition (i.e. diarrhoea, impetigo), Ear check left and right, Skin check, Medication
type, Medication name, Medication indication, Medication instructions. One quarter of par-
ticipants were randomly selected and their electronic health records manually reviewed to
ensure all relevant data was adequately captured by the automated script.
Data definitions
PHC encounters were presentations to the PHC service or a home visit by a health practi-
tioner. Multiple encounters occurring on the same day were recorded as one encounter. Anti-
biotics were defined as prescribed if they were recorded in either the medication type,
medication name or medication instructions fields. Infections were grouped into eight head-
ings to allow for analysis of appropriateness of antibiotic prescription and defined by identify-
ing string variables (listed below) in the Clinical items, Condition, Ear check left and right,
Skin check or Medication indication fields.
Terms used in the electronic records to describe infections:
1. Diarrhoeal (diarrhoea, gastroenteritis, giardia, loose or runny stool)
2. Lower Respiratory Tract Infection (LRTI) (bronchitis, bronchiolitis, pneumonia, wheeze)
3. Upper Respiratory Tract Infection (URTI) (chest infection, cough, cold, congestion, croup,
runny nose, sinusitis, sore throat, tonsillitis)
4. Acute otitis media (AOM) (otitis media, AOM)
5. Chronic suppurative otitis media (CSOM) (chronic otitis media, pus in ears)
6. Infected scabies (includes scabies diagnosis with either sores, impetigo or pustules)
7. Scabies (scabies diagnosis with no evidence of infection)
8. Skin Infection (abscess, boil, cellulitis, impetigo, pustules, sores, skin infection)
CARPA STM 7th edition was used to determine whether antibiotic use was provided as
indicated for the infectious classifications listed above (Table 1). [6]
Spectrum of activity was defined for Penicillins and Cephalosporins in accordance with the
Therapeutic Guidelines (2017), [20] i) broad spectrum antibiotics included: Amoxycillin Cla-
vulanate, Azithromycin, Ceftriaxone, Ciprofloxacin, Erythromycin, Metronidazole and Sulfa-
methoxazole & Trimethoprim, ii) moderate spectrum antibiotics included: Amoxycillin,
Table 1. Antibiotics recommended by CARPA standard treatment manual [6] by infection.
Diarrhoea LRTI URTI AOM CSOM Infected Scabies Skin infection
Amoxycillin - ✓ ✓ ✓ ✓ - -
Amoxycillin- Clavulanate - ✓ - ✓ - - -
Azithromycin - ✓ - - - - -
Benzathine Penicillin - ✓ ✓ - - ✓ ✓
Cephalexin - ✓ - - - - ✓
Ciprofloxacin - - - ✓ ✓ - -
Flucloxacillin - - - - - - ✓
Metronidazole ✓ - - - - - -
Procaine Penicillin - ✓ ✓ - - - ✓
Sulfamethoxazole & Trimethoprim ✓ - - ✓ - ✓ ✓
https://doi.org/10.1371/journal.pone.0231798.t001
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Ampicillin and Cephalexin and iii) narrow spectrum antibiotics included: Benzathine Penicil-
lin, Phenoxymethyl Penicillin, Flucloxacillin and Procaine Penicillin.
Low Birth Weight (LBW) was defined as<2.5kg, and term at birth was defined as i) Pre-
term<37 weeks completed gestation, ii) Term�37 weeks gestation [21].
Data analysis
Outcome measures were: primary health care encounters, infectious presentations, antibiotic
prescription rate, factors associated with antibiotic prescriptions and factors associated with
appropriate antibiotic prescription. All data was analysed in STATA 16. [22]
Number of PHC encounters, infectious encounters and encounters recording an antibiotic
prescription were reported as medians with interquartile ranges (IQRs) and stratified by age in
years. Differences in median prescriptions by age, birth status and season were assessed by
quantile (median) regression. Descriptive data for infectious encounters and infection type
were reported as percentages. Antibiotic prescription rate for infectious encounters was
reported as mean and standard deviation. Differences in the proportion of single infection or
multiple infection encounters receiving antibiotics and receiving appropriate antibiotics was
assessed via two tailed proportions test. Risk ratios (RR) were used to assess the risk of differing
infections on antibiotic prescription–either alone as single infection encounters, alongside
another as a multiple infection encounter, or in total.
For single infection encounters, a comparison of one particular infection was made with
other single infections (i.e. single infection diarrhoea encounters vs. single infection non-diar-
rhoea encounters). Similarly, within multiple infection encounters all those containing a par-
ticular infection to those not containing this infection (i.e. multiple infection encounters
containing diarrhoea vs. multiple infection encounters not containing diarrhoea). Finally, an
overall risk comparing presence of a particular infection, regardless of single or multiple infec-
tion encounters, to infectious encounters without that particular infection (i.e. infectious
encounters with diarrhoea vs. infectious encounters without diarrhoea). Logistic regression
was used to assess the impact of short term (30-day period) infection recurrence on appropri-
ateness of antibiotic prescriptions and reported as odds ratios (ORs).
Results
Consent was obtained from 149 mothers to extract data from 196 child records. Seventy-two
children were excluded from the analysis because; the records contained no data from the first
two years of life (n = 5, 8%), the child was born after 31 July 2014 (n = 32, 44%), or the child
was born prior to 1 January 2010 (n = 35, 49%). The 124 child records included represented
~69% of the eligible population, of which the majority (n = 81, 65%) were born at term weigh-
ing�2.5kg, 16 (13%) were term and LBW, 13 (10%) were preterm weighing�2.5kg and 14
(11%) were preterm and LBW (Table 2).
For the 124 children there were 5,675 PHC encounters in the first two years of life, median
41 (IQR 25.5, 64) encounters per child and 1,468 antibiotic prescriptions. In the first year of
Table 2. Gestation and birthweight of children born 2010–2014.
n = 124 (%)
Term &�2.5 kg 81 (65)
Term & LBW 16 (13)
Preterm &�2.5 kg 13 (10)
Preterm and LBW 14 (11)
https://doi.org/10.1371/journal.pone.0231798.t002
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life, 123 (99%) children were seen with 2,938 PHC encounters (median 22, IQR 14, 32) for
whom 111 (90%) had an infection recorded (median 6, IQR 3, 9) and 111 (90%) had antibiot-
ics prescribed (median 5, IQR 3, 9) (Fig 1). In the second year of life, 122 (99%) children had
2,737 PHC encounters (median 17.5, IQR 11, 31) for whom 120 (99%) had an infection
recorded (median 5.5 IQR 3, 9) and 117 (96%) had antibiotics prescribed (median 6, IQR 3, 8).
No significant difference in PHC encounters, infectious encounters or antibiotic prescriptions
was observed by age, birth status (LBW or preterm) or between seasons (wet or dry). The
mean prescription rate for children was 5.99/person-year (95%CI 5.35–6.63).
The majority of prescriptions were broad spectrum (n = 822, 56%) (Fig 2) of which Amoxy-
cillin (n = 797, 54%) was the single most recorded prescription, followed by Benzathine Peni-
cillin (n = 160, 11%).
For the 111 children who had an antibiotic prescription in the first year of life, the median
age for the first prescription was four months (IQR 2–5). By 12 months of age, 90% of children
had been prescribed an antibiotic (Fig 3).
Fig 1. Median PHC encounters and antibiotic prescriptions per child, in the first and second year of life. (The
figure is split to show first and second year of life. The blue boxes show the range of PHC encounters per child and the
green boxes the range of recorded antibiotic prescriptions for the first and second year of life).
https://doi.org/10.1371/journal.pone.0231798.g001
Fig 2. Prescriptions by spectrum of activity. (The total number of recorded antibiotic prescriptions by spectrum of
activity, from left to right—Narrow, Moderate and Broad).
https://doi.org/10.1371/journal.pone.0231798.g002
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Of the 5,675 PHC encounters, there were 1,542 (27%) with infections recorded, of which
1,342 (87%) encounters had a single infection and 200 (13%) encounters had multiple infec-
tions (two infections n = 181, three infections n = 18, four infections n = 1). For all infections
(n = 1,777), the proportion of PHC encounters reporting single infections (n = 1,342 75%) was
greater than those for multiple infections (Table 3). Within encounters recording multiple
infections, AOM, CSOM and URTI were the most common co-infections.
Of the 1,542 encounters reporting an infection, 962 (62%) encounters had a record of an
antibiotic prescription (mean prescription rate 0.69 ± 0.597). For the 1,342 single infection
encounters, 795 (59%) recorded an antibiotic prescription, while of the 200 multiple infection
encounters, 167 (84%) recorded an antibiotic prescription. Of the 795 recorded prescriptions
for single infection encounters, 691 (87%) were appropriate and for the 167 multiple infection
encounters, 161 (96%) were appropriate. The difference in proprtion of prescriptons and
appropriateness of prescriptions between single and multiple infection encounters was statisti-
cally significant (p<0.0001 & p = 0.0002 respectively).
Fig 3. Cumulative incidence of first antibiotic prescription by age in months. (The bars represent the cumulative
number of children who had an antibiotic prescription recorded by that age, while the line represents the cumulative
proportion. Note two participants received an antibiotic in their first month of life, therefore the values do not start at
zero. The dotted lines show the proportion of children who have received an antibiotic prescription prior to six and 12
months respectively).
https://doi.org/10.1371/journal.pone.0231798.g003
Table 3. Number and percentage of single or multiple infections. (Column 2 shows the number and proportion of infections that occurred alone in a Single Infection
Encounter. Column 3 shows the number and proportion of infections that occurred alongside at least one other infection in a Multiple Infection Encounter (note that as
this column shows the number of infections (n = 435), the total value exceeds that of the number of multiple infection encounters (n = 200)). Column 4 shows the top
three co-infections and the percentage of multiple infection encounters they were reported in for that infection).
Single Infection n (%) Multiple Infection n (%) Top three co-infections (%) Total n (%)
Diarrhoea 126 (78) 36 (22) AOM (64), URTI (25) & CSOM (19) 162 (9)
LRTI 34 (87) 5 (13) URTI (60), AOM (20) & CSOM (20) 39 (2)
URTI 210 (72) 82 (28) AOM (68), CSOM (15) & Diarrhoea (11) 292 (16)
AOM 530 (78) 153 (22) URTI (37), CSOM (25) & Skin (22) 683 (38)
CSOM 74 (54) 63 (46) AOM (62), URTI (19) & Skin (14) 137 (8)
Infected Scabies� 14 (74) 5 (26) AOM (80), Skin (80) & Diarrhoea (20) 19 (1)
Scabies 192 (88) 27 (12) AOM (48), CSOM (30), URTI (19) 219 (12)
Skin infection 162 (72) 64 (28) AOM (52), CSOM (11) & URTI (9) 211 (12)
Total 1,342 (75) 435 (25) - 1,777
�Skin infection alongside infected scabies is for alternate skin infection presentations i.e. boils or cellulitis
https://doi.org/10.1371/journal.pone.0231798.t003
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Among encounters with a single infection recorded, AOM had the highest proportion of
antibiotic prescriptions (83%) and accounted for more than half of the total antibiotic pre-
scriptions (n = 439, 56%) (Table 4). Furthermore, all but eight (2%) AOM prescriptions were
considered appropriate. Of the scabies infections which recorded antibiotic prescriptions 31
(63%) received Benzathine Penicillin. Other antibiotic prescriptions recorded for scabies
included: Amoxycillin; n = 7, Amoxycillin/Clavulanate, Sulfamethoxazole & Trimethoprim
and Flucloxacillin; n = 3, Azithromycin, Cephalexin and Procaine Penicillin; n = 1.
PHC encounters with AOM recorded had a significantly greater risk of antibiotic prescrip-
tion than for any other infection, regardless if presenting as a single infection (RR 3.32, 95% CI
2.72, 4.05) or as part of a multiple infection encounter (1.31 95% CI 0.99, 1.75) (Table 5). Anti-
biotics were significantly less likely to be prescribed if the encounter recorded either diarrhoea
or a skin infection.
Almost two thirds (n = 954, 65%) of antibiotic prescriptions were prescribed for infections
that aligned with what was recommended by CARPA standard treatment manual (Table 6). Of
the encounters where a prescription without an infection was recorded (n = 398, 27%), Amox-
ycillin was the most common prescription (n = 176, 44%). Amoxycillin was also the most fre-
quent antibiotic presribed for infections that aligned with CARPA (76%).
Looking to participants who presented with multiple episodes of the same infection in a
one calender month time span, the prescription pattern and appropriateness of prescriptions
differed between infections. The majority of first time AOM infectious presentations (n = 536)
received an appropriate antibiotic prescription (n = 454, 85%) (Table 7). The proportion of
appropriate prescriptions declined significantly with recurrent visits (OR 0.54, 95% CI 0.39,
Table 4. Antibiotic appropriateness by infection (single infection encounters only).
Antibiotic Prescribed n (%) Aligned Prescription n (%) Non Aligned Prescription n (%)
Diarrhoea (n = 126) 30 (24) 24/30 (80) 6/30 (20)
LRTI (n = 34) 24 (71) 22/24 (92) 2/24 (8)
URTI (n = 210) 128 (61) 104/128 (81) 24/128 (19)
AOM (n = 530) 439 (83) 431/439 (98) 8/439(2)
CSOM (n = 74) 42 (57) 37/42 (88) 5/42 (12)
Infected scabies (n = 19) 12 (86) 10/12 (83) 2/12 (17)
Scabies (n = 192) 49 (26) 0/49 (0) 49/49 (100)
Skin Infection (n = 162) 71 (44) 63/71 (89) 8/71 (11)
Total (n = 1,342) 795 (59) 691/795 (87) 70/795 (13)
https://doi.org/10.1371/journal.pone.0231798.t004
Table 5. Number and percentage of single and multiple infections and the risk ratio for having an antibiotic prescribed compared to other infections.
Single infections for which an antibiotic was
prescribed n = 795 (%) RR (95% CI)
Multiple infections for which an antibitoic
was prescribed n = 167 (%) RR (95% CI)
Any infection for which an antibiotic was
prescribed n = 962 (%) RR (95% CI)
Diarrhoea 30 (4) 0.22 (0.15, 0.32) 24 (14) 0.40 (0.22, 0.71) 54 (6) 0.30 (0.22, 0.41)
LRTI 24 (3) 1.65 (0.80, 3.43) 3 (2) 0.30 (0.05, 1.71) 27 (3) 1.36 (0.69, 2.66)
URTI 128 (16) 1.07 (0.83, 1.39) 73 (44) 1.60 (0.90, 2.87) 201 (21) 1.33 (1.06, 1.67)
AOM 439 (55) 3.32 (2.72, 4.05) 133 (80) 1.31 (0.99, 1.75) 572 (59) 3.11 (2.61, 3.7)
CSOM 42 (5) 0.90 (0.58, 1.41) 54 (32) 1.19 (0.65, 2.16) 96 (10) 1.41 (0.99, 2.01)
Infected Scabies 12 (2) 4.13 (0.93, 18.37) 4 (3) 0.79 (0.09, 6.85) 16 (2) 3.22 (0.94, 10.99)
Scabies 49 (6) 0.24 (0.17, 0.32) 23 (14) 1.14 (0.42, 3.07) 72 (8) 0.30 (0.23, 0.38)
Skin Infection 71 (9) 0.54 (0.40, 0.72) 35 (21) 0.49 (0.30, 0.81) 106 (11) 0.61 (0.47, 0.78)
https://doi.org/10.1371/journal.pone.0231798.t005
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0.75, p<0.001, R2 = 0.0196) (Fig 4). Diarrhoeal infections displayed the opposite trend, with
the first visit having few presciptions (27%) and low appropriateness (13%) which increased
significantly with recurrence (OR 5.27, 95% CI 2.39, 11.6, p<0.001, R2 = 0.1229).
Table 6. Prescriptions administered when indicated in accordance with CARPA.
Aligned with CARPA n = 954
(%)
Not aligned n = 116
(%)
No infection recorded n = 398
(%)
Total Prescriptions n = 1468
(%)
Amoxycillin 607 (76) 14 (2) 176 (22) 797 (54)
Amoxycillin Clavulanate 69 (54) 34 (26) 26 (20) 129 (9)
Ampicillin 0 (0) 0 (0) 1 (100) 1 (0)
Azithromycin 0 (0) 3 (75) 1 (25) 4 (0)
Benzathine Penicillin 76 (48) 34 (21) 50 (31) 160 (11)
Ceftriaxone 0 (0) 5 (45) 6 (55) 11 (1)
Cephalexin 7 (29) 10 (42) 7 (29) 24 (2)
Ciprofloxacin 107 (74) 1 (1) 37 (26) 145 (10)
Erythromycin 0 (0) 1 (33) 2 (67) 3 (0)
Flucloxacillin 18 (49) 5 (14) 14 (38) 37 (3)
Metronidazole 30 (58) 2 (4) 20 (39) 52 (4)
Phenoxymethyl Penicillin 0 (0) 2 (100) 0 (0) 2 (0)
Procaine Penicillin 29 (37) 2 (3) 48 (61) 79 (5)
Sulfamethoxazole &
Trimethoprim
11 (46) 3 (13) 10 (42) 24 (2)
https://doi.org/10.1371/journal.pone.0231798.t006
Table 7. Number of repeated infectious encounters over calender month, the proportion which received antibiotics and the appropriateness of antibiotics.
Recurrent encounters within calender month
1 2 3 4 OR (95% CI)
Diarrhoea Presentation 136 21 5 5.27 (2.39, 11.6)
Treated 37 (27) 13 (62) 4 (80)
Appropriate 17 (13) 9 (43) 4 (80)
LRTI Presentation 35 4 1.69 (0.21, 13.5)
Treated 23 (66) 4 (100)
Appropriate 13 (37) 2 (50)
URTI Presentation 261 27 3 1 1.08 (0.59, 1.97)
Treated 178 (68) 20 (74) 2 (67) 1 (100)
Appropriate 147 (56) 14 (52) 2 (67) 1 (100)
AOM Presentation 536 123 22 2 0.54 (0.39, 0.75)
Treated 464 (87) 90 (73) 17 (77) 1 (50)
Appropriate 454 (85) 86 (70) 16 (73) 1 (50)
CSOM Presentation 106 25 6 0.42 (0.21, 0.82)
Treated 77 (73) 14 (56) 5 (83)
Appropriate 70 (66) 10 (40) 2 (33)
Infected Scabies Presentation 19 -
Treated 16 (84)
Appropriate 12 (63)
Scabies Presentation 187 29 3 -
Treated 57 (30) 14 (48) 1 (33)
Appropriate 0 0 0
Skin infection Presentation 192 17 2 0.6 (0.23, 1.6)
Treated 99 (52) 6 (35) 1 (50)
Appropriate 70 (37) 3 (18) 1 (50)
https://doi.org/10.1371/journal.pone.0231798.t007
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Discussion
Australian Aboriginal children in remote communities had exceptionally high levels of antibi-
otic prescriptions in comparison to Australian values reported previously. [2, 5, 8, 23] By 12
months of age, 90% of Aboriginal children in this study had received at least one antibiotic
prescription, comparable to that previously reported in East Arnhem (95%) [9] and six of eight
low- and middle-income countries (LMICs) in the MAL-ED study (80–100%), [24] but signifi-
cantly higher than reported in a regional centre in Victoria (50%) [23] and previous reports
from Europe (18–55%). [25] The prescription rate among Aboriginal children per person year
(5.99, 95% CI 5.35, 6.63) in this study was six times higher than that reported for children in
regional Victoria (0.92, 95% CI 0.83, 1.02) [23] and slightly higher than the average 4.9 antibi-
otic courses per person year in the MAL-ED countries. [24]
Similarities in antibiotic prescriptions can be seen between the current setting and LMICs.
A recent report using retrospective data from eight LMICs estimated 62.3% and 63.2% of chil-
dren aged zero and one years respectively presented to a health care service with infection and
received an antibiotic prescription—similar to this study in which 62% of infectious encoun-
ters recorded an antibiotic prescription. [26] Comparing specific infections and antibiotic pre-
scriptions, in the current study 33% of diarrhoeal episodes recorded antibiotic prescriptions,
similar to the average reported across countries in the MAL-ED study. [24] Respiratory infec-
tions however were significantly more likely to receive antibiotics in the current study than
any site in the MAL-ED study, with 67% receiving antibiotics compared to 62.8% for the high-
est site (Haydom, Tanzania) and 43.5% for the MAL-ED sites overall. [24] In the study by Fink
et al. (2019) mean antibiotic prescription per sick child visit was 0.66 (SD 0.547) and 0.67 (SD
0.553) in the first and second year of life, comparable to the overall 0.69 (SD 0.597) in the cur-
rent study. [26]
Amoxycillin was the most commonly prescribed antibiotic, accounting for more than half
the total prescriptions (54%). This is higher than usage reported through the PBS (43.7%) [8]
and through parental or community reporting (55%—this figure includes Ampicillin and
Amoxycillin/Clavulanate). [23] It is noteworthy that in this remote setting, the use of narrow
Fig 4. The proportion of infectious encounters which received an antibiotic prescription by infection recurrence within a one calender month time period. (The
top bar for each graph shows the proportion of participants who presented with the respective infection for the first time in a calendar month and recorded an antibiotic
prescription which was either appropriate (green) or inappropriate (orange). The second bar down shows the proportion of children who presented for that infection a
second time in a calendar month and recorded an antibiotic prescription. The third and fourth bars show the same for the third and fourth presentations within a
calendar month respectively. Absent bars may represent either there was no recurrent visit, or recurrent visits did not receive any antibiotic).
https://doi.org/10.1371/journal.pone.0231798.g004
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spectrum antibiotics was significantly higher than that reported previously through the PBS (19%
vs 9%). [27] High prescription rates of moderate and broad spectrum antibiotics contribute more
to the spread of antibiotic resistance due to cross resistance than do narrow spectrum antibiotics.
[27, 28] Thus, although the prescription rate is higher in this remote setting, the ratio of broad to
narrow spectrum antibiotic prescriptions is lower than reported in urban settings.
The high rates of antibiotic prescription are attributable to an underlying burden of disease
that is substantially higher in Aboriginal children than non-Aboriginal children. [29–31] Chil-
dren presented with an infection a median 6 (IQR 3–9) and 5.5 (IQR 3–9) times in their first
and second year of life respectively, which is consistent with the mean antibiotic prescription
rate noted (5.99, 95% CI 5.35, 6.63). If this prescription rate continued it would be similar to
LMICs which reported a mean 36 (95%CI 33.8, 38.3) sick visits by the age of five years. [26] In
the current study, AOM was the most common infection, recorded alone in 30% of infectious
encounters, and alongside other infections in an additional 8%. The majority of encounters
with AOM alone (n = 530) had an antibiotic prescription recorded (n = 439, 83%), which
accounted for more than half the total prescriptions recorded among single infection encoun-
ters (n = 783, 56%). Of the encounters which recorded an Amoxycillin prescription 60%
(n = 478) also recorded AOM. In comparison to the wider Australian community, 15% of
Amoxycillin prescriptions nationally were used to treat AOM. [2]
Though single infection encounters were more common (86% of infectious encounters),
multiple infection encounters accounted for 25% of the total infection burden. Multiple infec-
tion encounters were significantly more likely to receive antibiotics compared to single infec-
tion encounters (84% vs 59%) and for these to be appropriate antibiotics (98% vs 91%). AOM
and URTIs were the most common concurrent infections, present in 34% and 18% of multiple
infection encounters respectively. However, the presence of any one particular infection did
not increase the likelihood of receiving antibiotics which is likely due to the high prescription
rate already present. These aspects together highlight the role the underlying burden of disease
plays in antibiotic prescription rates in remote communities. Cunningham et al. (2019) esti-
mated a 6% absolute reduction in antibiotic prescriptions if skin infections were eliminated in
their studied communities. [9] Our data indicate an absolute reduction of 4% in antibitoic pre-
scription rates if skin infections were eliminated. If AOM were eliminated in these three com-
munities however, we estimate a 30% absolute reduction.
This study is the first to report on appropriateness of prescriptions within remote Aborigi-
nal Australian communities, and previous reports have noted the need for such data. [2, 9, 19]
In this study, 65% of prescriptions had recorded infections that aligned with CARPA guide-
lines. Only 8% of prescriptions had an infection recorded which did not align, and 27% of pre-
scriptions had no infection recorded, significantly lower than that reported in AURA 2017. (2)
In the case of non-infected scabies, for which one quarter of single infection encounters
received an antibiotic, 63% of these encounters received Benzathine Penicillin which is indi-
cated in cases of infected scabies. We are unable to differentiate if this was inappropriate use of
Benzathine Penicillin or if scabies that were infected were not recorded correctly in the elec-
tronic health records.
Appropriateness of prescriptions aside, the high rate of prescriptions is a potential issue in
and of itself. Antibiotic use in infancy is associated with a long-term shift in the gut micro-
biome which may further increase the risk of non-communicable chronic disease (NCDs) in
this vulnerable population. [32] According to a 2016 report, the burden of disease among
Aboriginal Australians is 2.3 times that of non-Aboriginal Australians, with 70% of this
accounted for by chronic disease. [33] Around one-third of this is considered preventable by
modifying classic risk factors (ie. Tobacco, body mass, diet, physical inactivity) [33] however,
the current study suggests an additional avenue for NCD mitigation, by addressing the
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underlying burden of infectious disease in infancy and subsequent antibiotic prescriptions
which alter the gut microbiome.
The temporal dimension of antibiotic prescriptions is often unexplored. This study pro-
vides a comprehensive description of infections and the appropriateness of antibiotic prescrip-
tions. It is noteworthy that for less potentially serious infections, (i.e. diarrhoea, URTIs)
antibiotic prescription at the first visit tended to be low but increasing over time with recurrent
encounters. This may indicate that infections were thought to be parasitic or viral and required
other first line treatment measures.
Legislative requirements placed on nurses and Aboriginal Health Practitioners to adhere to
the guidelines when supplying and administering antibiotics is an effective mechanism to limit
inappropriate antibiotic use in this setting. [34] For the more prominent infections (AOM and
CSOM) appropriate prescriptions were high initially but dwindled over time with recurrence.
However, those that did receive an antibiotic prescription were more likely to be receiving a
repeat prescription. This is likely a reflection of the context these communities are in. Both
AOM and CSOM are endemic within such communities and have significant sequalae. Thus,
health practitioners have greater motivation to treat promptly and offer longer courses of anti-
biotics to ensure successful treatment.
A major strength of the current study is the level of clinical information available within the
electronic health record. The majority (73%) of antibiotic prescriptions had an infection listed,
allowing for more accurate determination of appropriateness in comparison to AURA 2017
(23.5% had infections recorded). [2] The automated script used to withdraw relevant data from
the electronic health record is a significant advantage over manual review of all progress notes.
Once all data fields were entered into the automated script, less than 1% of observations were
found to have additional data within the progress notes. This gives a strong base from which to
develop ongoing surveillance processes to monitor antimicrobial stewardship. One major limita-
tion of this study is the binary view taken to determine appropriateness of antibiotic prescriptions.
This assumes that all clinically relevant data has been entered by the frontline staff in extractable
sections (not progress notes), and that any infections present were at a level which required antibi-
otic intervention. Another potential limitation is missing data, as children may have travelled to
other communities, collected a prescription there and on returning home presented for repeats at
their home PHC–thus contributing to the number of ‘inappropriate’ prescriptions.
Conclusion
Antibiotic prescription rates among Australian Aboriginal children living in remote commu-
nities are significantly higher than that reported for non-Aboriginal Australians. The majority
of antibiotic prescriptions are appropriate and driven by a higher underlying burden of disease
thus, the consequences of a potential rise in antibiotic resistance are significant. Compared to
urban centres, the ratio of broad to narrow spectrum antibiotic prescriptions is positive, sug-
gesting awareness of appropriate antimicrobial stewardship in these communities. However,
the high prescription rates in infancy may have some contribution to chronic disease later in
life. Within these communities a focus on promoting the underlying determinants of health is
critical to reduce the burden of disease which underpins antibiotic prescription rates.
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